PMA

P150031: VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM

FDA PMA · Stimulator, electrical, implanted, for parkinsonian symptoms · Boston Scientific Corp

Key facts

PMA number P150031
Trade name VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM
Generic name Stimulator, electrical, implanted, for parkinsonian symptoms
Applicant Boston Scientific Corp
Owner/operator Boston Scientific Corporation
Product code NHL
Approval date Dec 8, 2017
Docket number 17M-6800
Notice date Dec 15, 2017
Establishment registration 2124215
FEI number 2124215

At a glance

  • 10–99 Supplements
  • Sep 22, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals